# FDA recall D-0286-2022

> **Sandoz Inc** · Class I · drug recall initiated 2021-11-17.

## Product

Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Rx Only; 0.4 mL Syringes, Manufactured for Sandoz Inc., Princeton, NJ 08540, NDC 00781-3246-02; Carton (10 x 0.4 mL Syringes), Manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd. Shenzhen City, Guangdong Province 518057, China for Sandoz Inc., Princeton, NJ 08540, NDC 00781-3246-64

## Reason for recall

Temperature Abuse; temperature excursion during shipping

## Distribution

Nationwide in the US

## Key facts

- **Recall number:** D-0286-2022
- **Recalling firm:** Sandoz Inc
- **Classification:** Class I
- **Product type:** drug
- **Status:** Completed
- **Initiation date:** 2021-11-17
- **Report date:** 2021-12-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0286-2022

## Citation

> AI Analytics. FDA recall D-0286-2022. Retrieved 2026-07-15 from https://api.ai-analytics.org/recall/D-0286-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*